Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease. - Wikidata - awgldk - TriplyDB

Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease.

Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease.

http://www.wikidata.org/entity/Q37143598

about

Cobalamin deficiency, hyperhomocysteinemia, and dementia Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology Circulating biomarkers that predict incident dementia.Blood-based biomarkers of Alzheimer's disease: challenging but feasible An overview of longitudinal data analysis methods for neurological research.Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.Biomarkers of Alzheimer's disease: from central nervous system to periphery?Decreased C-reactive protein levels in Alzheimer disease C-reactive protein is related to memory and medial temporal brain volume in older adults.Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants.Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI Change in plasma Aß peptides and onset of dementia in adults with Down syndrome.Age-dependent inverse correlations in CSF and plasma amyloid-β(1-42) concentrations prior to amyloid plaque deposition in the brain of 3xTg-AD mice Biomarkers of basic activities of daily living in Alzheimer's disease.Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship.Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial.Biomarkers of Alzheimer's disease in body fluids.Meta-analysis of plasma amyloid-β levels in Alzheimer's disease.Rapid cognitive decline in Alzheimer's disease: a literature review.Hypoxia and inflammation in children with sickle cell disease: implications for hippocampal functioning and episodic memory.Elevated Plasma Aβ42 in Cognitively Impaired Individuals Taking ACE Inhibitor Antihypertensives.Biochemical and Radiological Markers of Alzheimer's Disease Progression.Potential peripheral biomarkers for the diagnosis of Alzheimer's disease.The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.Diagnosis of Alzheimer's disease in Brazil: Supplementary exams.The association of high sensitivity C-reactive protein and incident Alzheimer disease in patients 60 years and older: The HUNT study, Norway.Potential blood biomarker for disease severity in the Taiwanese population with Alzheimer's disease.Clinical and Radiological Differences in Alzheimer's Disease with and without a History of Mild Cognitive Impairment.Neuroinflammation in Alzheimer's Disease: Pleiotropic Roles for Cytokines and Neuronal Pentraxins.Amyloid β Peptides and Cognitive Functions in Patients with Pseudoexfoliation Syndrome.Cerebrospinal fluid β-amyloid 1-42 correlates with rate of progression in Alzheimer's disease.Association between the characteristics of metabolic syndrome and Alzheimer's disease.The Clinical Significance and Potential Role of C-Reactive Protein in Chronic Inflammatory and Neurodegenerative Diseases.Systemic Inflammation Is Associated With Longitudinal Changes in Cognitive Performance Among Urban Adults

P2860

Q24609123-42885F15-E041-4B3B-B66E-2FE9DCCFE158 Q26774743-29EC5488-371C-444A-B469-543F95948EEA Q33752058-520EBAEE-E255-44CD-86ED-363C602B0C5E Q33824444-7322E62A-93FD-41E1-A52B-FB20EC51F4B0 Q34112927-56CA42F2-A553-4DF6-8668-128C20064113 Q34277859-983F89F9-7E42-4DA8-BB68-0503C4EF503F Q34442605-5E9F05FA-8793-4F0F-A87A-8DCC68164081 Q35482118-BC2ED96E-8495-427C-AEC2-55DEFB78A73E Q35566761-4C5CBBDC-E6CA-4166-B051-C70C7D2EA79B Q35601036-2051636E-19A1-4323-B75F-3A9C91108A4D Q35821382-4E5C2FA2-7EFF-4C18-A6A3-8D4EDAA49FA9 Q36064807-C0AEBC0E-6E3D-4DC3-BAF3-FCB61CC9854E Q36528218-54373425-4A14-4569-B53E-5EB49EC83224 Q36818214-504109C3-DDAD-4A65-984B-9C2B7A9D4311 Q36998414-4E64FC40-E8E8-4755-A1BA-741F80F4484B Q37069901-15A9943D-DA00-4166-B777-3E62B101E678 Q37180577-9C607F29-FF76-4BA6-94AA-EEF46E8BD0E7 Q37769463-6E77566E-E5E4-4C58-9761-C441054C346C Q37895050-C552A578-A8A1-4CE3-8BED-855FCB50B6B7 Q38178371-D8912CD3-864E-451D-B544-FC144867807C Q38205407-63F78DF8-EB02-472C-8038-46C0DEAB993B Q38690145-4DC3348C-CF1C-4E83-80A0-FCB72AFC12E2 Q38693438-93ABFCC7-313B-4BB0-BAD8-44AB3D37AFD0 Q38833738-92B86C4E-9344-4DF5-B429-547A30AE69FA Q44801837-CCD1A53F-6BBE-4BEF-A8D9-4D5B942D09A8 Q47142477-0322A33A-5FBB-46CC-86D8-6A2250528F7B Q47550084-44FA331C-82A1-47C4-B1A9-D0A2A6CC5E2F Q48257794-D2C2D78C-5803-44A7-947E-C14610D3FC3F Q48955678-770F2403-51AE-4206-9AA0-652380C5D55C Q49808096-6162D964-2954-4703-B508-93AC368FB48E Q50580013-4ACEED36-2A8C-40BB-9EE0-03B2EDFE2CFB Q50763390-0AFF6B74-8AC8-4D25-861E-C7BD49D0BD81 Q51018894-C028B2A0-8998-4510-8FF8-C8CBADC65E25 Q55373841-55720936-5537-4D9A-B16E-184AD83A2718 Q57816573-3A02A31E-2FD7-4725-8A47-90D2C0969D8D

P2860

Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease.

http://www.wikidata.org/entity/Q37143598

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Plasma amyloid beta-protein an ...... gression of Alzheimer disease.

@en

Plasma amyloid beta-protein an ...... gression of Alzheimer disease.

@nl

type

label

Plasma amyloid beta-protein an ...... gression of Alzheimer disease.

@en

Plasma amyloid beta-protein an ...... gression of Alzheimer disease.

@nl

prefLabel

Plasma amyloid beta-protein an ...... gression of Alzheimer disease.

@en

Plasma amyloid beta-protein an ...... gression of Alzheimer disease.

@nl

P1433

Q37143598-4CAE7744-37C3-42F7-95F5-AE01620E1B7B

P1476

Q37143598-12429A7F-3700-47FC-B44E-2A73534A24FD

P2093

Q37143598-0558238E-9B31-41D6-BEA1-A0420A076CD8

Q37143598-602722F3-E672-491A-A1B3-D5769CB4DD7B

Q37143598-8F660C51-56CB-4FDD-BB15-B2E0C815D42B

Q37143598-ACB5EF5E-BB25-44CC-83B0-33CE87F260C9

Q37143598-CA760989-1F87-4CD0-9011-14C857DF8225

Q37143598-FC643EFA-9975-4CB8-8CD8-66FFA3491D23

P2860

Q37143598-0764B4D8-3487-4F9C-8AB4-1A4A93DCA8C9

Q37143598-094D0E50-E461-4617-9F93-A9FC7AA36A64

Q37143598-0D5F790D-74E2-4755-9FCB-FE4181E0B4C2

Q37143598-0DBE8F34-D016-40FB-B5F0-C20219793FE9

Q37143598-0FDB92C1-7807-435F-B998-87BCEA7D8FD8

Q37143598-1B76027D-7ECF-4CA7-AB08-F67FF924BBA3

Q37143598-2991F4FB-B50F-4436-9541-DDE76B10C0ED

Q37143598-5326BBA1-B1BE-4B1C-A2F6-CE53A9563B9B

Q37143598-590C2EEB-DA0B-4CBF-BE0C-D943AEB3F0B8

Q37143598-59BAF8FF-22AC-42DD-8160-BBBA149B5D55

P304

Q37143598-BAF212B8-C209-4654-A289-877A604F65FD

P31

Q37143598-92F7D9DB-1370-4888-8093-9C534E7C3029

P356

Q37143598-9488CA83-7B4A-4E7C-9A95-7A978C4B33ED

P433

Q37143598-36D64F11-0DD5-425E-81D9-66C0F7081586

P478

Q37143598-EDA7FAA4-B151-4DEF-B14C-00EE8CF952B1

P50

Q37143598-B0F0FEDD-6983-45AF-A0D8-C1D2B6D7930F

P577

Q37143598-EDE59DC4-230D-4E66-8392-C767C483DE77

P5875

Q37143598-804666EE-ACF6-492E-A76E-1B74943E3151

P698

Q37143598-5368DEFB-C399-4677-AE00-F49EECD7B27A

P921

Q37143598-FC655760-CBC8-4A8E-8AD8-B5414B72103D

P932

Q37143598-1AB42C10-00EC-4195-B7DF-A849BF02317F

P356

ARCHNEUR.65.6.776

P1433

P1476

Plasma amyloid beta-protein an ...... gression of Alzheimer disease.

@en

P2093

Hiroaki Fukumoto

http://www.w3.org/2001/XMLSchema#string

John H Growdon

http://www.w3.org/2001/XMLSchema#string

Joseph J Locascio

http://www.w3.org/2001/XMLSchema#string

Liang Yap

http://www.w3.org/2001/XMLSchema#string

Michael C Irizarry

http://www.w3.org/2001/XMLSchema#string

Teodoro Bottiglieri

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

Facts and recommendations about total homocysteine determinations: an expert opinion.

Biomarkers of Alzheimer disease in plasma

Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study.

Monitoring progression in Alzheimer's disease.

Cognitive test performance in detecting, staging, and tracking Alzheimer's disease.

The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease.

The consortium to establish a registry for Alzheimer's disease (CERAD). Part XIV: Demographic and clinical predictors of survival in patients with Alzheimer's disease.

P304

776-785

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUR.65.6.776

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5315212

http://www.w3.org/2001/XMLSchema#string

P698

18541797

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2662621

http://www.w3.org/2001/XMLSchema#string